Abstract
Because of the various causes of pediatric heart failure （circulatory failure）, there are few strong evidences regarding drug treatment for pediatric heart failure. Using drugs aimed at improving hemodynamics （catecholamines, diuretics, etc.）, monitoring hemodynamics and clinical conditions enable us to judge the therapeutic value of the drugs. However, it is impossible to judge the effectiveness of the drugs aimed at improving prognosis （blockades of renin-angiotensin-aldosterone system and beta-blockers） from each of the patients. Using the latter drugs, we have to make the therapeutic plans based on a few reports in pediatric patients and many reports in adult patients with heart failure.
